Kids & teens (for parents) · Iowa
Studies for children and teens in Iowa
These studies only enroll people under 18. A parent or legal guardian gives permission, and children old enough to understand are asked for their own agreement (assent).
12 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 3
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Pfizer
- Location
- Ankeny, IA + 101 other US sites
- Eligibility basics
- Ages 1 mo–7 mo
- RecruitingPhase 3
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Lumos Pharma
- Location
- Iowa City, IA + 30 other US sites
- Eligibility basics
- Ages 3–11
- RecruitingPhase 2
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
argenx
- Location
- Iowa City, IA + 10 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 2
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
Scholar Rock, Inc.
- Location
- Iowa City, IA + 11 other US sites
- Eligibility basics
- Up to age 2
- RecruitingPhase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Pfizer
- Location
- Sioux City, IA + 69 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Pfizer
- Location
- West Des Moines, IA + 54 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
AbbVie
- Location
- Ames, IA + 87 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Takeda
- Location
- Iowa City, IA + 9 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 2/Phase 3
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
Chiesi Farmaceutici S.p.A.
- Location
- Iowa City, IA + 5 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Iowa City, IA + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 2
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
BioMarin Pharmaceutical
- Location
- Iowa City, IA + 30 other US sites
- Eligibility basics
- Ages 3–11
- RecruitingHealthy volunteersPhase 4
Stimulant Effects on Disruptive Behavior
Matthew J O'Brien, PhD, BCBA-D
- Location
- Iowa City, IA
- Eligibility basics
- Ages 4–12